Novo Nordisk invests $100M for new Chinese R&D facility

Novo Nordisk A/S (CSE:NVO; NYSE:NVO) plans to invest $100 million to build a new R&D facility in Beijing, China. The new center will be located in the Zhongguancun Life Science Park, where Novo has an...